BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15386209)

  • 21. Dry powder inhalers (DPIs)--a review of device reliability and innovation.
    Islam N; Gladki E
    Int J Pharm; 2008 Aug; 360(1-2):1-11. PubMed ID: 18583072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device.
    van Beerendonk I; Mesters I; Mudde AN; Tan TD
    J Asthma; 1998; 35(3):273-9. PubMed ID: 9661680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):72-80. PubMed ID: 16442248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inhalation therapy with Respimat soft inhaler in patients with COPD and asthma].
    Voshaar T; Hausen T; Kardos P; Köhler D; Schultze-Werninghaus G; Schürmann W; Vogelmeier C
    Pneumologie; 2005 Jan; 59(1):25-32. PubMed ID: 15685486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhalation therapy of the future--how will it change the way we treat asthma?
    Lötvall J
    J Aerosol Med; 2001; 14 Suppl 1():S45-50. PubMed ID: 11424893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Could interchangeable use of dry powder inhalers affect patients?
    Price D; Summers M; Zanen P
    Int J Clin Pract Suppl; 2005 Dec; (149):3-6. PubMed ID: 16279996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can patients use all dry powder inhalers equally well?
    Gustafsson P; Taylor A; Zanen P; Chrystyn H
    Int J Clin Pract Suppl; 2005 Dec; (149):13-8. PubMed ID: 16279998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is new in asthma: new dry powder inhalers.
    Hannemann LA
    J Pediatr Health Care; 1999; 13(4):159-65. PubMed ID: 10690079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idealhalers or realhalers? A comparison of Diskus and Turbuhaler.
    Borgström L; Asking L; Thorsson L
    Int J Clin Pract; 2005 Dec; 59(12):1488-95. PubMed ID: 16351685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New liquid aerosol generation devices: systems that force pressurized liquids through nozzles.
    Geller DE
    Respir Care; 2002 Dec; 47(12):1392-404; discussion 1404-5. PubMed ID: 12467498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methods for administration of anti-asthma inhalation drugs].
    Fjellbirkeland L; Gulsvik A
    Tidsskr Nor Laegeforen; 1990 Jun; 110(16):2092-5. PubMed ID: 2368076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State of the art and new perspectives on dry powder inhalers.
    Terzano C; Colombo P
    Eur Rev Med Pharmacol Sci; 1999; 3(6):247-54. PubMed ID: 11261735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide.
    Thorsson L; Geller D
    Respir Med; 2005 Jul; 99(7):836-49. PubMed ID: 15939245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of co-milling techniques for the production of high dose dry powder inhaler formulation.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1229-1238. PubMed ID: 28367654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do all dry powder inhalers show the same pharmaceutical performance?
    Taylor A; Gustafsson P
    Int J Clin Pract Suppl; 2005 Dec; (149):7-12. PubMed ID: 16279997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ambulatory criteria of dry powder inhaler selection based on peak inspiratory flow recordings].
    Droszcz W; Droscez P
    Pneumonol Alergol Pol; 2002; 70(9-10):490-5. PubMed ID: 12710102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
    Onoue S; Misaka S; Kawabata Y; Yamada S
    Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The best way to apply aerosol therapy. I--Methods].
    Battistini A
    Pediatr Med Chir; 1995; 17(2):97-103. PubMed ID: 7610089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What plays a role in the choice of inhaler device for asthma therapy?
    Virchow JC
    Curr Med Res Opin; 2005; 21 Suppl 4():S19-25. PubMed ID: 16138941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.